hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate
CORTISPORIN (hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate) by Monarch Therapeutics is clinical pharmacology colistin sulfate is a polypeptide antibiotic which penetrates into and disrupts the bacterial cell membrane. Approved for superficial bacterial infections of the external auditory canal, caused by organisms susceptible to the action of the antibiotics. First approved in 1963.
Drug data last refreshed 3h ago · AI intelligence enriched 1mo ago
Cortisporin is a topical combination cream containing hydrocortisone acetate (corticosteroid), neomycin sulfate (aminoglycoside antibiotic), and polymyxin B sulfate (polypeptide antibiotic) for treating superficial bacterial infections of the external auditory canal. The triple-agent formulation provides anti-inflammatory and broad-spectrum bactericidal coverage against gram-positive and gram-negative organisms including Staphylococcus aureus, Pseudomonas aeruginosa, and Enterobacteriaceae.
Product is approaching loss of exclusivity with moderate competitive pressure (30%), indicating contraction phase that will shrink brand team headcount and shift focus to cost management and generic transition planning.
CLINICAL PHARMACOLOGY Colistin sulfate is a polypeptide antibiotic which penetrates into and disrupts the bacterial cell membrane. Neomycin sulfate is an aminoglycoside antibiotic which inhibits protein synthesis, disrupting the normal cycle of ribosomal function. Hydrocortisone acetate is a…
Worked on CORTISPORIN at Monarch Therapeutics? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on Cortisporin offers limited career growth potential given its LOE-approaching lifecycle and minimal linked job activity (0 postings). Roles available are primarily commercial and operational, focused on defending a shrinking generic topical market rather than innovation or expansion—better suited for cost-management and transition planning experience than for building a high-growth resume.